Emerging Treatment Models in Rheumatology: IgG4‐Related Disease: Insights Into Human Immunology and Targeted Therapies
- 2 June 2017
- journal article
- review article
- Published by Wiley in Arthritis & Rheumatology
- Vol. 69 (9) , 1722-1732
Abstract
No abstract availableKeywords
Funding Information
- National Institutes of Health (5U19-AI-110495, T32-AR-007258)
- Rheumatology Research Foundation
- National Institute of Allergy and Infectious Diseases (5U19AI110495)
This publication has 61 references indexed in Scilit:
- CS1, a SLAM family receptor involved in immune regulation, is a therapeutic target in multiple myelomaCritical Reviews in Oncology/Hematology, 2013
- Consensus statement on the pathology of IgG4-related diseaseLaboratory Investigation, 2012
- Development of an IgG4-RD Responder IndexInternational Journal of Rheumatology, 2012
- Numerous IgG4-positive plasma cells are ubiquitous in diverse localised non-specific chronic inflammatory conditions and need to be distinguished from IgG4-related systemic disordersJournal of Clinical Pathology, 2011
- Human Blood CXCR5+CD4+ T Cells Are Counterparts of T Follicular Cells and Contain Specific Subsets that Differentially Support Antibody SecretionImmunity, 2011
- Mechanisms that determine plasma cell lifespan and the duration of humoral immunityImmunological Reviews, 2010
- Mechanisms of killing by anti-CD20 monoclonal antibodiesMolecular Immunology, 2007
- Th2 and regulatory immune reactions are increased in immunoglobin G4-related sclerosing pancreatitis and cholangitisHepatology, 2007
- Generation of migratory antigen-specific plasma blasts and mobilization of resident plasma cells in a secondary immune responseBlood, 2005
- A new clinicopathological entity of IgG4-related autoimmune diseaseJournal of Gastroenterology, 2003